BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18364015)

  • 41. [When native arteriovenous fistula is not possible: the permanent catheter is better].
    Coli' L; Cuna V; Capelli I; Kwin C; Donati G; La Manna G; Stefoni S
    G Ital Nefrol; 2009; 26(2):154-7. PubMed ID: 19382070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preservation of vascular access for hemodialysis in acute care settings.
    Richard CJ
    Crit Care Nurs Q; 2011; 34(1):76-83. PubMed ID: 21160304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. End-stage vascular access: direct intra-atrial insertion of a dialysis catheter.
    Wales L; Anderson JR; Power A; Dosani T; Hakim NS
    Exp Clin Transplant; 2008 Jun; 6(2):169-70. PubMed ID: 18816246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study.
    Saran R; Elder SJ; Goodkin DA; Akiba T; Ethier J; Rayner HC; Saito A; Young EW; Gillespie BW; Merion RM; Pisoni RL
    Ann Surg; 2008 May; 247(5):885-91. PubMed ID: 18438128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology of hemodialysis vascular access in the United States.
    Lacson E
    Clin Nephrol; 2011 Jun; 75(6):497-505. PubMed ID: 21612752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical practice guidelines for vascular access. Canadian Society pf Nephrology.
    Ethier JH; Lindsay RM; Barre PE; Kappel JE; Carlisle EJ; Common A
    J Am Soc Nephrol; 1999 Jun; 10 Suppl 13():S297-305. PubMed ID: 10425613
    [No Abstract]   [Full Text] [Related]  

  • 47. [Vascular access for hemodialysis--own experiences].
    Dziekiewicz M; Wierzbicki P; Prokopiuk-Wierzbicka M; Obara A; Wańkowicz Z; Maruszyński M
    Pol Merkur Lekarski; 2008 Apr; 24(142):316-20. PubMed ID: 18634363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case of fatal cardiac tamponade during hemodialysis.
    Schmiege LM; Wolf DA
    Semin Dial; 2006; 19(5):434-7. PubMed ID: 16970747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An overview of permanent vascular access in hemodialyzed patients.
    ChecheriŢă IA; TuŢă LA; David C; Peride I; Niculae A; Geavlete BF; Pricop C; Ion DA
    Rom J Morphol Embryol; 2015; 56(1):27-31. PubMed ID: 25826484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The role of the nephrologist in the management of vascular access for hemodialysis].
    D'Amico M; Fraticelli M; Mangano S; Bonforte G
    G Ital Nefrol; 2007; 24(6):605-8. PubMed ID: 18278765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors influencing the prevalence of central venous catheter use in a Canadian haemodialysis centre.
    Graham J; Hiremath S; Magner PO; Knoll GA; Burns KD
    Nephrol Dial Transplant; 2008 Nov; 23(11):3585-91. PubMed ID: 18552397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascular access management III: central venous catheters.
    McCann M; Einarsdottir H; Van Waeleghem JP; Murphy F; Sedgewick J
    J Ren Care; 2010 Mar; 36(1):25-33. PubMed ID: 20214706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Malfunction of dialysis catheters: management of fibrin sheath and related problems.
    Faintuch S; Salazar GM
    Tech Vasc Interv Radiol; 2008 Sep; 11(3):195-200. PubMed ID: 19100950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A challenge for nephrologists--increasing fistula maturation rates, reducing fistula maturation time, and decreasing dialysis catheter prevalence in the United States.
    Levine MI
    Semin Dial; 2008; 21(3):280-4. PubMed ID: 18533969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting hemodialysis access failure with the measurement of dialysis access recirculation.
    Salimi J; Razeghi E; Karjalian H; Meysamie A; Dahhaz M; Dadmehr M
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):781-4. PubMed ID: 18711295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transhepatic venous access as an alternative for Tesio catheter in the case of a patient on haemodialysis with antiphospholipid syndrome.
    Rosa-Diez GJ; Lambertini RG; Peralta O; Diodato LH; Algranati SL; García-Mónaco RD
    Nephrol Dial Transplant; 2006 Jul; 21(7):2031-3. PubMed ID: 16464883
    [No Abstract]   [Full Text] [Related]  

  • 57. Managing venous stenosis in vascular access for haemodialysis.
    Yap HY; Robless PA; Lee JC; Wang SC
    Singapore Med J; 2007 Jan; 48(1):6-10; quiz 11. PubMed ID: 17245509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. International pediatric fistula first initiative: a call to action.
    Chand DH; Valentini RP
    Am J Kidney Dis; 2008 Jun; 51(6):1016-24. PubMed ID: 18501786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodialysis fistula interventions: diagnostic and treatment challenges and technical considerations.
    Nikolic B
    Tech Vasc Interv Radiol; 2008 Sep; 11(3):167-74. PubMed ID: 19100945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central vein obstruction in vascular access.
    Mickley V
    Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):439-44. PubMed ID: 16765068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.